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Semen quality is affected by environmental factors, endocrine function abnormalities, 
and genetic factors. A GWAS recently identified ERBB4 at 2q34 as a genetic locus 
associated with sperm motility. However, GWASs for human semen volume and sperm 
concentration have not been conducted. In addition, testis size also reportedly correlates 
with semen quality, and it is important to identify genes that affect testis size. 
Reproductive hormones also play an important role in spermatogenesis. To date, genetic 
loci associated with plasma testosterone, sex hormone-binding globulin (SHBG), follicle 
stimulating hormone (FSH), and luteinizing hormone (LH) levels have been identified
using GWASs. However, GWASs have not identified any relevant loci for plasma inhibin 
B levels. We conducted a two-stage GWAS using 811 Japanese men in a discovery stage 
followed by a replication stage using an additional 721 Japanese men. The results of the 
discovery and replication stages were combined into a meta-analysis. After setting a 
suggestive significance threshold for P values < 5 × 10-6 in the discovery stage, we 
identified ten regions with SNPs (semen volume: one, sperm concentration: three, testes 
size: two, and inhibin B: four). We selected only the most significant SNP in each region 
for replication genotyping. Combined discovery and replication results in the meta-
analysis showed that the locus 12q21.31 associated with plasma inhibin B levels
(rs11116724) had the most significant association (P = 5.7 × 10-8). The LRRIQ1 and 
TSPAN19 genes are located in the 12q21.31 region. This study provides new susceptibility 






Examination of male infertility requires a semen test. The World Health 
Organization [1] has established the test criteria, which include semen volume, sperm 
concentration, and sperm motility. Thus, semen quality affects fertility. Semen quality is 
affected by environmental factors like smoking and stress, endocrine function 
abnormalities including testosterone, and genetic factors. Regarding genetic factors, 
polymorphisms of circadian regulator (CLOCK) [2] and steroid -reductase 2 (SRD5A2)
[3] genes are reportedly associated with human semen volume. It has been reported that 
protamine 1 (PRM1), PRM2 [4], deleted in azoospermia-like (DAZL) [5], CLOCK [2], 
cytochrome P450 family 19 subfamily A peptide 1 (CYP19A1) [6], histidine-rich 
glycoprotein (HRG) [7], and voltage-dependent anion channel (VDAC) [8] gene
polymorphisms show significant association with human semen concentration. Genome-
wide association studies (GWASs) are widely used to identify variants associated with 
diseases and quantitative traits. We used a GWAS to identify ERBB4 at 2q34 as a locus 
associated with sperm motility [9]. However, GWASs for human semen volume and 
sperm concentration have not been conducted yet, and the related genetic factors are 
poorly understood. In addition, testis size has also been reported to correlate with sperm 
density, total sperm count, and total motile sperm count [10]. Thus it is important to 
identify the genes that affect testis size.
Hormones are physiologically active substances that are synthesized and 
secreted by endocrine glands, such as the thyroid and pituitary glands. They act on target 
cells via blood and other pathways. Very small hormone amounts can have regulatory 
effects on digestive absorption, circulation, respiration, immunity, and metabolism, and 





stimulating hormone (FSH) and luteinizing hormone (LH), are produced by the pituitary 
gland after stimulation by gonadotropin-releasing hormone. In the testes, secreted LH 
induces testosterone secretion by Leydig cells, and FSH promotes spermatogenesis in 
Sertoli cells in the presence of testosterone [11,12]. Approximately 50 to 60% of 
testosterone in circulation binds to sex hormone-binding globulin (SHBG), which 
decreases its biological activity [13]. Inhibin B produced in Sertoli cells acts on the 
hypothalamus pituitary system in a negative feedback loop along with estradiol to inhibit 
FSH production. These hormones play an important role in sexual development, 
spermatogenesis, and testicular function maintenance in men [14,15]. Since these 
hormone values are heritable, genetic factors are thought to exist [16]. GWASs have 
shown that genetic loci associated with reproductive hormone levels exist in some 
populations. SHBG (rs12150660, rs6258, rs727428, and rs2075230), family with 
sequence similarity 9 member B (FAM9B) (rs5934505), and Jumonji domain-containing 
1C (JMJD1C) (rs10822184) are loci significantly associated with testosterone levels in 
European and Chinese populations [17-19]. SHBG (rs12150660, rs6258, rs2075230, and 
rs12150660), protein arginine methyltransferase 6 (PRMT6) (rs17496332), glucokinase 
regulator (GCKR) (rs780093), zinc finger and BTB domain containing 10 (ZBTB10)
(rs440837), JMJD1C (rs7910927), solute carrier organic anion transporter family 
member 1B1 (SLCO1B1) (rs4149056), nuclear receptor subfamily 2 group F member 2 
(NR2F2) (rs8023580), zinc finger protein 652 (ZNF652) (rs2411984), teratocarcinoma-
derived growth factor 3 (TDGF3) (rs1573036), and BAI1 associated protein 2 like 1 
(BAIAP2L1) (rs3779195) are loci significantly associated with SHBG levels in European
and Chinese populations [17,19,20]. CYP19A1 (rs2414095) and follicle stimulating 





levels in the Chinese population and United Kingdom twin data [17,21]. FSHB
(rs11031002) is a locus significantly associated with LH levels in United Kingdom twin 
data [21]. However, a GWAS focusing on reproductive hormones in the Japanese 
population has not been conducted, and inhibin B level-related loci have not yet been 
identified using GWASs.
Here, we conducted a GWAS in 811 Japanese men to clarify the genetic 
determinants of human semen volume, sperm concentration, testis size, and plasma 
inhibin B levels for which genetic loci have not yet been identified. The associations were 
validated in an additional Japanese man. For SNPs that were indicated to be related, we 
also investigated the association with other parameters and male infertility. In addition, 
we conducted the validation analyses of previously known SNPs that have shown 
genome-wide significant associations with testosterone, SHBG, FSH or LH associated in 








This study was approved by the ethics committees each university and hospital.
All participants provided written informed consent.
We performed a two-stage genetic association study. The discovery stage 
included 811 men (20.7 ± 1.7 years old, mean ± SD) from the general Japanese population 
who were recruited from university students in three study centers based in departments 
of urology at university hospitals in Japan (Kawasaki, Kanazawa, and Nagasaki) as 
previously reported [22]. The replication stage included 721 men (31.1 ± 4.8 years old, 
mean ± SD) of proven fertility recruited from the partners of pregnant women who 
attended obstetric clinics in four cities in Japan (Sapporo, Kanazawa, Osaka, and 
Fukuoka) [23]. The characteristics for the two stage subjects are summarized in Table 1.
Clinical trait measurements
Clinical trait measurement for these subjects has been described in previous 
reports [22,23]. Briefly, age, body weight, height, and ejaculation abstinence period were 
self-reported. BMI (kg/m2) was calculated from body weight and height. Semen samples 
were obtained once by masturbation after sexual abstinence for at least 48 h and were 
ejaculated into clean, wide-necked, sterile, nontoxic collection containers. The samples 
were protected from extreme temperatures and liquefied at 37°C before examination. 
Semen volume was measured with a graduated 5 ml syringe (Terumo; Tokyo, Japan). 
The sperm concentration of each sample was assessed using a Bürker-Türk
hemocytometer. Testis sizes were measured using a Prader Orchidometer (Pharmacia & 





the testicular size. Blood samples were drawn from the cubital vein of each subject usually 
in the mornings to reduce the effect of diurnal variations in hormone levels. Inhibin B 
was measured using a specific two-sided enzyme immunometric assay (Serotec, 
Kidlington, UK). Testosterone, SHBG, FSH, and LH levels were determined using a 
time-resolved immunofluorometric assay (Delfia, Wallac, Turku, Finland) at the 
Department of Growth and Reproduction, Rigshospitalet, in Copenhagen, Denmark.
Genotyping, quality control and imputation
Genomic DNA was extracted from the peripheral blood samples of subjects 
using a QIAamp DNA blood kit (Qiagen; Tokyo, Japan). Previously genotyped and 
imputed data were used in the discovery stage [9]. Briefly, 816 men were genotyped using 
the Illumina HumanCore V1.0 DNA Analysis Kit (Illumina; Tokyo, Japan) following the 
manufacturer’s instructions. 298,930 SNPs were genotyped. The quality control of 
genotyped SNPs and samples was conducted using the PLINK version 1.07 software 
package (http://pngu.mgh.harvard.edu/~purcell/plink/) [24]. Of the 816 samples, four 
were excluded because there were duplicates or familial relationships and one was 
excluded because it was genetic outlier based on a principle component analysis-based 
method using the genotyped data of the HapMap CHB and JPT as internal controls. 
Finally, 811 samples were included for genome-wide association analysis. For genotype 
imputation, we filtered out 56,462 SNPs from our data set according to the following 
criteria: without reference SNP (rs) ID, monomorphic in our sample set, with call rates 
lower than 0.98, or genotyped by duplicated probes. There were no SNPs excluded based 
on the Hardy-Weinberg equilibrium test (P 1.0×10-6). Genotype data were flipped to 





using genotype data for Asian samples (JPT and CHB) of the 1000 Genomes Project
[27,28] as a reference panel. Imputation was performed using BEAGLE 4.1. 1000 
Genomes Project Phase 3 v5 was used as a reference panel. SNPs with R2 lower than 0.8 
and all indels were excluded from imputed genotype data. Finally, we obtained genotypes 
for 3,901,256 SNPs, which were used for subsequent association analyses.
In the replication stage, SNPs were genotyped using TaqMan probes 
(rs13400448, C_31177579_10; rs1501607, C_1490652_10; rs7724206, 
C_27428161_10; rs1761601, C_1803412_10; rs8179990, C_29718786_10; rs6955111, 
Custom; rs2346597, C_15778404_10; rs4870827, C_28925_10; rs2440587, 
C_16240853_10; rs12817187, C_32172890_10; rs149500, C_ 2025086_10; rs11116719, 
C_ 2025119_10; and rs11116724, C_12125451_10; Applied Biosystems; Tokyo, Japan) 
with the ABI 7900HT real-time PCR system (Applied Biosystems).
rs12817187 and rs11116724 were directly genotyped in 200 randomly selected 
samples of discovery subjects to confirm the concordance of imputed results. The 
concordance of typing results between genotyped and imputed was 100%.
Statistical analysis
The analyses for semen volume and sperm concentration were processed using 
square-root-transformed. Testosterone, SHBG, FSH, and LH were processed using 
natural log-transformed to minimize deviation from a normal distribution.
In the discovery and replication stage, the associations between SNPs and testis 
size, and hormone values were assessed using a standardized multiple linear regression 
under an additive genetic model with adjustments for age and BMI using PLINK or the 





concentration were additionally adjusted for ejaculation abstinence, and sperm motility 
was additionally adjusted for ejaculation abstinence and time from masturbation to semen 
evaluation. We set a suggestive threshold of P values < 5 × 10-6 in the discovery stage. 
The results from the discovery and replications were combined in a meta-analysis using 
the meta package for the R software. The extent of heterogeneity among studies was 
quantified using the I2 statistic [29] and statistically assessed using Cochran’s Q test. If 
there was no heterogeneity based on an I2 statistic < 50% or a P-value > 0.1, a fixed-
effects model using the inverse variance method was used. Otherwise, the random-effects 
model using the DerSimonian and Laird method was used.
The Manhattan and quantile-quantile plots were generated using qqman package 
for the R software, and the regional plot was created by LocusZoom using the 1000 
Genomes project Asian (ASN) data (Nov 2014) [30]. HaploReg V 4.1 
(http://archive.broadinstitute.org/mammals/haploreg/haploreg.php) was used for 
functional annotation analysis of variants [31]. Significantly expressed quantitative trait 







GWAS for semen volume, sperm concentration, testis size, and plasma inhibin B 
levels
We conducted a two-stage GWAS to identify loci associated with human semen 
volume, sperm concentration, testis size, and plasma inhibin B levels. Manhattan plots 
and quantile-quantile plots of the GWAS were presented in Figure 1 and Supplementary 
Figure S1, respectively. The genomic-control inflation factors of semen volume, 
sperm concentration, testis size, and inhibin B level were 1.00650, 1.00875, 1.00000, and 
1.01398, respectively, indicating the unlikelihood of inflation of the false-positive 
association. We could not find any SNPs that reached the genome-wide significance level. 
Therefore, we set a suggestive threshold of P values < 5.0 × 10-6. The 2p16.1 locus was 
suggestively associated with semen volume, the 3q26.31, 5q23.1, and 10p15.1 loci were 
suggestively associated with sperm concentration, the 3q13.11 and 7q22.1 loci were 
suggestively associated with testis size, and the 4q13.1, 8q24.13, 9q22.31, and 12q21.31 
loci were suggestively associated with plasma inhibin B levels (Supplementary Table S1).
We conducted a replication study for the most significant SNPs (rs13400448 at 
2p16.1, rs1501607 at 3q26.31, rs7724206 at 5q23.1, rs1761601 at 10p15.1, rs8179990 at 
3q13.11, rs6955111 at 7q22.1, rs2346597 at 4q13.1, rs4870827 at 8q24.13, rs2440587 at 
9q22.31, and rs12817187 at 12q21.31) at each locus. In the replication stage with 721 
men, rs12817187 showed a significant association with plasma inhibin B levels 
P = 3.9× 10-3) (Table 2). However, none of the SNPs displayed any association with 
semen volume, sperm concentration, and testis size. When we combined the discovery 
and replication stages using meta-analysis, we found that rs12817187 had a suggestive
association P = 9.5 × 10-8) with plasma inhibin B levels (Table 2). The variance 
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in inhibin B level based on rs12817187 was 1.8%. 
To confirm the most significant SNP in the region where rs12817187 is located, 
we selected rs1494500, rs11116719, and rs11116724, which are SNPs with P values < 1.0 
× 10-5 and not completely in linkage disequilibrium with the rs12817187 SNP that 
indicated association with plasma inhibin B levels (Supplementary Table S2), and 
conducted a replication study. When we combined the discovery and replication stages 
using meta-analysis, we found that rs11116724 was most significantly associated 
0.22, P = 5.7 × 10-8) with plasma inhibin B levels (Table 3).
Association of rs11116724 with other parameters and male infertility
We further analyzed the association of the rs11116724 SNP with other 
parameters (including semen volume, sperm concentration, testis size, plasma 
testosterone, SHBG, FSH, and LH levels) and risk of male infertility (including
nonobstructive azoospermia, oligozoospermia, and asthenozoospermia) (Supplementary 
Materials and Methods). rs11116724 was marginally associated with sperm concentration 
P = 0.042) and testis size P = 0.036) (Supplementary Table S3). 
However, these associations were not significant after adjusting for plasma inhibin B 
levels (data not shown). This is mainly because plasma inhibin B levels are positively 
correlated with sperm concentration and testis size (Supplementary Table S4). rs11116724 
did not indicate significant association with male infertility risk (Supplementary Table 
S5).
Functional annotations





shown in Figure 2. rs11116724 is located in the intron of leucine rich repeats and the IQ 
motif containing 1 (LRRIQ1) gene, and the LRRIQ1 and tetraspanin 19 (TSPAN19) genes 
are located in the 12q21.31 region.
We used the HaploReg database to obtain putative functional annotations of 
these loci [32]. The summary of SNPs in high LD compared to rs11116724 based on the 
HaploReg database is shown in Supplementary Table S6. Of the 103 SNPs in high LD,
rs7312075, rs3765044 and rs17012533 were missense variants in the LRRIQ1 gene. We 
predicted the effect of three SNPs on LRRIQ1 function using two in silico SNP prediction 
algorithms: Sorting Intolerant From Tolerant (SIFT) [33] and PolyPhen-2 [34]. rs7312075 
was one of three SNPs classified as damaging using SIFT analysis (Supplementary Table 
S7). Although the most significant SNP, rs11116724, was not associated with promoter 
histone marks, enhancer histone marks, DNase I hypersensitive regions, and protein 
binding, 33 other SNPs were associated with promoter histone marks, enhancer histone 
marks, DNase I hypersensitive regions in various cell types and tissues, and/or protein 
binding. 93 SNPs, including rs11116724, could alter nucleotide sequences of several 
regulatory motifs. In addition, we found that rs11116724 was a significant eQTL for 
TSPAN19 in the testes. The effect allele (A) of rs11116724 was associated with decreased 
TSPAN19 (P = 1.1 × 10-5) expression in the testes according to the GTEx Portal V8 
(Supplementary Figure S2) [32].
GWAS for testosterone, SHBG, FSH, and LH in Japanese
Next, we conducted a GWAS for testosterone, SHBG, FSH, and LH, whose loci 
were identified by previous GWASs, on 811 Japanese men. Manhattan plots and quantile-





respectively. However, none of the SNPs reached the genome-wide significance level (P
< 5.0 × 10-8). In addition, the results of the association analysis between hormone levels 
in Japanese men and reported SNPs that reached the genome-wide significance levels 
were summarized in Supplementary Table S8. rs2075230, which was reported to be 
strongly associated with SHBG levels (P = 4.75×10-19) in Chinese men, showed the 






In this GWAS for human semen volume, sperm concentration, testis size, and 
plasma inhibin B levels, we showed that locus 12q21.31 is suggestively associated with 
plasma inhibin B levels. This association was also validated at different ages between the 
same ethnic groups.
The LRRIQ1 and TSPAN19 genes are located in the 12q21.31 region. LRRIQ1 is 
most strongly expressed in the testes and strongly localized to the seminiferous ducts in 
the testes. LRRIQ1’s function is not well understood, but it interacts with 28 proteins like
activin A receptor type 1 (ACVR1), activin A receptor type 2A (ACVR2A), and activin A 
receptor type 2B (ACVR2B) [35]. Activin has the opposite effect to inhibin; it promotes 
FSH secretion. Activin receptor was identified in 1991 [36], and it was reported that 
inhibin also functions via a common receptor with activin [37]. Although it is not known 
how the interaction of the activin receptor and LRRIQ1 affects inhibin B levels, it may 
be that differences in inhibin B levels occur in response to signal changes from the 
receptor. TSPAN19, located in the 12q21.31 region, is a member of the tetraspanin family 
with four transmembrane domains, but its function is not well understood. TSPAN19 is 
strongly expressed in the testes and lungs and specifically localized to Leydig cells in the 
testes. Since inhibin B is secreted by Sertoli cells in the testes, LRRIQ1 and/or TSPAN19 
may somehow contribute to inhibin B secretion. We could not find significant eQTL for
LRRIQ1 in the testes, but three SNPs (rs7312075, rs3765044, and rs17012533) in high 
LD with the most significant SNP, rs11116724, were missense variants in the LRRIQ1
gene. rs7312075 was one of three SNPs to be classified as damaging based on SIFT and 
PolyPhen-2 analyses. Therefore, rs7312075 in high LD with rs11116724 damages 





rs11116724 was associated with decreased TSPAN19 expression in the testes according to 
the GTEx Portal V8. On the other hand, the effect allele of rs11116724 was associated 
with increased inhibin B levels. Thus, it is suggested that the effect allele of rs11116724 
increases inhibin B expression by decreasing TSPAN19 expression.
On the other hand, we could not identify the loci related to semen volume, sperm 
concentration, or testis size. No single SNP had a large effect size for these phenotypes. 
Thus, multi-factor inheritance or environmental factors may have an influence.
We could not identify novel SNPs that reached the genome-wide significance 
level for testosterone, SHBG, FSH, and LH in Japanese men. Some of the reported SNPs 
that reached the genome-wide significance levels showed association, but they did not 
reach the genome-wide significance level in Japanese men. This may be due to differences 
in sample size and/or ethnic group.
In conclusion, this GWAS identified the novel locus 12q21.31 as suggestively
associated with plasma inhibin B levels. LRRIQ1 and TSPAN19 genes are located in the 
12q21.31 region. LRRIQ1 and TSPAN19 are expressed specifically in the testes. The 
functions of these genes are unknown, but it has been suggested that these genes 
contribute to inhibin B secretion since inhibin B is secreted from Sertoli cells. Future 
studies are needed to identify functional variant(s) directly related to plasma inhibin B 
levels at this locus by targeted resequencing of the two candidate genes. In addition, future 
replication studies in diverse populations with larger sample sizes are essential since our 
association did not reach the genome-wide significance level.
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Figure 1. Manhattan plot from GWAS for semen volume (A), sperm concentration 
(B), testes size (C), and Inhibin B (D). The negative log10-transformed P values (y 
axis) of SNPs are shown according to their position on the chromosome. The horizontal 
line represents suggestive (P value = 5 × 10-6) (dotted line) and genome-wide (P value = 
5 × 10-8) (solid line) threshold.
Figure 2. Regional plot of the associations between SNPs at the region 400 kb 
upstream or downstream of lead SNP of inhibin B. The negative log10-transformed P
values (y axis) of the genotyped and imputed SNPs are shown according to their 
position. Purple diamond indicates the lead SNP, and color indicates LD strength with 
the lead SNP. The right Y-axis shows the recombination rate estimated from the 1000





















































Table 1. Characteristics of subjects
Discovery (N=811) Replication (N=721)
Age (years) 20.7 ± 1.7 31.1 ± 4.8
BMI (kg/m2) 21.5 ± 2.5 23.3 ± 3.1
Ejaculation abstinence (hours) 79.8 ± 39.5 199.8 ± 338.2
Semen volume (ml) 2.9 ± 1.4 3.1 ± 1.5
Sperm concentration (×106/ml) 72.1 ± 56.9 106.7 ± 83.3
Testis size (ml) 20.8 ± 4.3 20.0 ± 3.6
Inhibin-B (pg/ml) 197.8 ± 63.9 177.0 ± 55.3
Testosterone (nmol/l) 23.1 ± 7.5 19.6 ± 6.7
SHBG (nmol/l) 26.5 ± 10.3 33.3 ± 14.6
FSH (U/l) 2.4 ± 1.2 4.1 ± 2.1
LH (U/l) 3.2 ± 1.3 3.7 ± 1.5
Data are presented as mean ± standard deviation. Testis size was calculated from an average of the left and right testis.
Abbreviations: BMI, body mass index; SHBG, sex hormone-binding globulin; FSH, follicle-stimulating hormone; LH, luteinizing hormone.
Table 2. Summary results for the most significant SNPs in loci identified the association for semen volume, sperm concentration, testis size, and 





Stage Genotype EAF STD (SE) P Pheta I2
(%)b
Semen volume
rs13400448 2p16.1 57,135,651 Discovery 144/391/276 0.42 -0.23 (0.048) 2.1 × 10-6
(C/T) Replication 117/336/268 0.40 -0.081 (0.053) 0.13
Meta-analysis -0.16 (0.074) 0.034 0.039 76.6
Sperm concentration
rs1501607 3q26.31 170,942,533 Discovery 86/348/377 0.32 0.24 (0.051) 1.6 × 10-6
(T/C) Replication 91/314/316 0.34 -0.0093 (0.054) 0.86
Meta-analysis 0.12 (0.12) 0.35 0.0006 91.5
rs7724206 5q23.1 119,614,887 Discovery 105/379/327 0.36 0.23 (0.050) 3.5 × 10-6
(C/A) Replication 94/324/303 0.36 -0.00095 (0.054) 0.99
Meta-analysis 0.12 (0.12) 0.32 0.0015 90.1
rs1761601 10p15.1 5,200,059 Discovery 9/168/634 0.11 -0.35 (0.075) 4.3 × 10-6
(T/C) Replication 2/153/566 0.11 -0.14 (0.088) 0.12
Meta-analysis -0.25 (0.11) 0.019 0.068 70.0
Testes size
rs8179990 3q13.11 103,776,410 Discovery 53/306/452 0.25 0.25 (0.055) 4.7 × 10-6
(T/C) Replication 59/294/368 0.29 0.0047 (0.57) 0.94
Meta-analysis 0.13 (0.12) 0.30 0.0018 89.7
rs6955111 7q22.1 99,582,199 Discovery 21/207/583 0.15 -0.33 (0.066) 6.6 × 10-7
(C/T) Replication 7/173/541 0.13 -0.036 (0.080) 0.65
Meta-analysis -0.19 (0.15) 0.20 0.0046 87.6
Inhibin B
rs2346597 4q13.1 63,939,334 Discovery 22/201/588 0.15 0.32 (0.067) 2.9 × 10-6
(C/T) Replication 21/207/493 0.17 0.0043 (0.068) 0.95
Meta-analysis 0.16 (0.16) 0.30 0.0012 90.5
rs4870827 8q24.13 123,946,041 Discovery 176/423/212 0.48 -0.23 (0.50) 3.2 × 10-6
(G/A) Replication 125/389/207 0.44 0.080 (0.054) 0.14
Meta-analysis -0.078 (0.16) 0.62 <0.0001 94.5
rs2440587 9q22.31 94,138,821 Discovery 57/297/457 0.25 0.27 (0.055) 1.4 × 10-6
(T/C) Replication 58/266/397 0.27 -0.023 (0.057) 0.69
Meta-analysis 0.12 (0.15) 0.40 0.0002 92.6
rs12817187 12q21.31 85,566,208 Discovery 53/322/436 0.27 0.26 (0.056) 4.2 × 10-6
(A/G) Replication 57/282/382 0.27 0.17 (0.057) 3.9 × 10-3
Meta-analysis 0.21 (0.040) 9.5 × 10-8 0.24 27.6
Data are shown as the estimated standardized linear regression statistic STD, SE, and P value using an additive genetic model with adjustments 
for age and BMI. Semen volume and sperm concentration were additionally adjusted for ejaculation abstinence. The semen volume and sperm 
concentration were processed using square-root-transformed values.
aCochran’s Q test heterogeneity P value.
bI2 heterogeneity index.
Abbreviations: SNP, single-nucleotide polymorphism; Chr, chromosome; EAF, effect allele frequency; STD, standardized regression coefficient.





Stage Genotype EAF STD (SE) P Phetb I2 (%)c
rs1494500 85,402,328 Discovery 55/319/437 0.26 0.25 (0.056) 5.3 × 10-6
(C/T) Replication 61/273/387 0.27 0.16 (0.056) 5.2 × 10-3
Meta-analysis 0.21 (0.040) 1.7 × 10-7 0.22 33.6
rs11116719 85,522,932 Discovery 55/320/436 0.27 0.26 (0.056) 4.8 × 10-6
(T/C) Replication 55/283/383 0.27 0.16 (0.057) 5.4 × 10-3
Meta-analysis 0.21 (0.040) 1.5 × 10-7 0.23 30.1
rs11116724 85,530,856 Discovery 55/321/435 0.27 0.26 (0.056) 5.0 × 10-6
(A/G) Replication 59/275/387 0.27 0.17 (0.057) 2.2 × 10-3
Meta-analysis 0.22 (0.040) 5.7 × 10-8 0.30 6.7
rs12817187a 85,566,208 Discovery 53/322/436 0.27 0.26 (0.056) 4.2 × 10-6
(A/G) Replication 57/282/382 0.27 0.17 (0.057) 3.9 × 10-3
Meta-analysis 0.21 (0.040) 9.5 × 10-8 0.24 27.6
Data are shown as the estimated standardized linear regression statistic STD, SE, and P value using an additive genetic model with adjustments 
for age and BMI.
ars12817187 is the most significant SNP in discovery stage.
bCochran’s Q test heterogeneity P value.
cI2 heterogeneity index.
Abbreviations: SNP, single-nucleotide polymorphism; Chr, chromosome; EAF, effect allele frequency; STD, standardized regression coefficient.
